EUVIMEDEUVIMED entdecken
Multizentrische StudieKohortenstudieOpen Access · CC BY 4.0

Duration of Folic Acid Supplementation and Adverse Pregnancy Outcomes: A Prospective Multicenter Cohort Study in China

Mingxuan Zhang, Hongzhao Yu, Hongtian Li iD, Yubo Zhou iD, Jianmeng Liu

Nutrients · 26.12.2025 · 18 (1) · 81

DOI: 10.3390/nu18010081 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Nutrients, online erschienen am 26.12.2025. Verfasst von Mingxuan Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Reproductive and Child Health/National Health Commission Key Laboratory of Reproductive Health, Peking University Health Science Center,…. Hauptthemen laut MEDLINE: Folic Acid, Dietary Supplements, Pregnancy Outcome, Pregnancy Complications. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Clinical Medicine Plus X—Young Scholars Project at Peking University, and the Fundamental Research Funds for the Central Universities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Folic acid supplementation (FAS) before and in early pregnancy prevents neural tube defects, but the benefits of extending FAS to late pregnancy on pregnancy outcomes remain unclear. We aimed to investigate the associations between duration of FAS and a spectrum of pregnancy outcomes, and to determine whether the associations were modified by maternal age or pre-pregnancy body mass index (BMI).

Methods

This prospective multicenter study included 15,694 singleton pregnancies. We used mixed-effects log-binomial regression models to estimate the adjusted risk ratios (aRRs) and 95% confidence intervals (CIs) for gestational diabetes mellitus (GDM), gestational hypertensive disorders (GHDs), pre-eclampsia, preterm birth, macrosomia, small (SGA) and large for gestational age (LGA), and the interaction effects of advanced maternal age and pre-pregnancy BMI.

Results

Of 15,694 women, 4523 (28.8%) did not take FAS before or during pregnancy, 2854 (18.2%) took FAS only during peri-pregnancy, 921 (5.9%) took FAS from peri- to mid-pregnancy, and 7396 (47.1%) took it through late pregnancy. Compared with women without FAS, those supplemented until mid-pregnancy were associated with lower risks of GHDs (aRR 0.84, 95% CI 0.74, 0.96) and pre-eclampsia (aRR 0.81, 95% CI 0.67, 0.97). Supplementation until late pregnancy was associated with lower risks of preterm birth (aRR 0.67, 95% CI 0.59, 0.76), SGA (aRR 0.74, 95% CI 0.63, 0.87), and LGA (aRR 0.88, 95% CI 0.79, 0.97). Among women of advanced maternal age or with overweight/obesity, supplementation until mid-pregnancy was associated with higher risk of GDM.

Conclusions

Extending FAS until mid-pregnancy is associated with lower risks of GHDs and preeclampsia, and extending it until late pregnancy is associated with lower risks of preterm birth, SGA, and LGA. However, women of advanced maternal age or with overweight/obesity should be cautious about prolonging FAS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Folic AcidDietary SupplementsPregnancy OutcomePregnancy ComplicationsHumansFemalePregnancyAdultProspective StudiesChinaBody Mass IndexPre-EclampsiaMaternal AgeInfant, NewbornPremature BirthHypertension, Pregnancy-InducedDiabetes, GestationalYoung AdultTime Factors

Stichwörter der Autor:innen

advanced maternal agefolic acidmaternal nutrientspre-pregnancy BMIpregnancy outcomes

Substanzen

Folic Acid

Autor:innen und Institutionen

  • Institute of Reproductive and Child Health/National Health Commission Key Laboratory of Reproductive Health, Peking University Health Science Center, 38 Xueyuan Rd., Beijing 100191, China.
  • Department of Epidemiology and Biostatistics, School of Public Health, Peking University Health Science Center, 38 Xueyuan Rd., Beijing 100191, China.
  • State Key Laboratory of Female Fertility Promotion, Peking University Third Hospital, Beijing 100191, China.

ORCID-Profile: Hongtian Li, Yubo Zhou

Förderung

  • National Natural Science Foundation of China
  • Clinical Medicine Plus X—Young Scholars Project at Peking University, and the Fundamental Research Funds for the Central Universities

Zitieren

APA

Zhang, M., Yu, H., Li, H., Zhou, Y., & Liu, J. (2025). Duration of Folic Acid Supplementation and Adverse Pregnancy Outcomes: A Prospective Multicenter Cohort Study in China. Nutrients, 18(1), 81. https://doi.org/10.3390/nu18010081

Vancouver

Zhang M, Yu H, Li H, Zhou Y, Liu J. Duration of Folic Acid Supplementation and Adverse Pregnancy Outcomes: A Prospective Multicenter Cohort Study in China. Nutrients. 2025;18(1):81. doi:10.3390/nu18010081

BibTeX
@article{Zhang2025,
  author = {Zhang, Mingxuan and Yu, Hongzhao and Li, Hongtian and Zhou, Yubo and Liu, Jianmeng},
  title = {Duration of Folic Acid Supplementation and Adverse Pregnancy Outcomes: A Prospective Multicenter Cohort Study in China},
  journal = {Nutrients},
  year = {2025},
  volume = {18},
  number = {1},
  pages = {81},
  doi = {10.3390/nu18010081}
}
Kostenlos starten →